GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Doximity Inc (NYSE:DOCS) » Definitions » EPS (Diluted)

Doximity (Doximity) EPS (Diluted) : $0.66 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Doximity EPS (Diluted)?

Doximity's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.24. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.66.

Doximity's EPS (Basic) for the three months ended in Dec. 2023 was $0.26. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.73.

Doximity's EPS without NRI for the three months ended in Dec. 2023 was $0.24. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.75.

During the past 12 months, Doximity's average EPS without NRIGrowth Rate was 26.40% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 45.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Doximity's highest 3-Year average EPS without NRI Growth Rate was 517.10% per year. The lowest was 45.60% per year. And the median was 281.35% per year.


Doximity EPS (Diluted) Historical Data

The historical data trend for Doximity's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doximity EPS (Diluted) Chart

Doximity Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
EPS (Diluted)
- 0.06 0.12 0.70 0.53

Doximity Quarterly Data
Mar19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.14 0.13 0.15 0.24

Competitive Comparison of Doximity's EPS (Diluted)

For the Health Information Services subindustry, Doximity's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doximity's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's PE Ratio distribution charts can be found below:

* The bar in red indicates where Doximity's PE Ratio falls into.



Doximity EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Doximity's Diluted EPS for the fiscal year that ended in Mar. 2023 is calculated as

Diluted EPS (A: Mar. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(112.818-0)/213.425
=0.53

Doximity's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(47.956-0)/200.463
=0.24

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doximity  (NYSE:DOCS) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Doximity EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Doximity's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Doximity (Doximity) Business Description

Traded in Other Exchanges
N/A
Address
500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Executives
Kira Scherer Wampler director C/O DOXIMITY, INC., 500 3RD STREET, SUITE 510, SAN FRANCISCO CA 94107
Craig Overpeck officer: See Remarks C/O DOXIMITY, INC., 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Timothy S Cabral director C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Anna Bryson officer: Chief Financial Officer C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Jeffrey Tangney director, 10 percent owner, officer: Chief Executive Officer C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Paul W. Jorgensen officer: Chief Revenue Officer 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Gilbert H Kliman director, 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Emergence Capital Partners Ii Lp 10 percent owner 160 BOVET ROAD, SAN MATEO CA 94402
Emergence Equity Partners Ii, L.p. 10 percent owner 160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Gp Partners, Llc 10 percent owner PIER 5, THE EMBARCADERO, STE 102, SAN FRANCISCO CA 94111-2094
Kevin Spain director C/O EMERGENCE CAPITAL, 160 BOVET ROAD, STE. 300, SAN MATEO CA 94402
Emergence Capital Opportunity I, L.p. 10 percent owner 160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Equity Partners Vi, L.p. 10 percent owner C/O EMERGENCE CAPITAL PARTNERS, 160 BOVET ROAD, SUITE 300 CA SAN MATEO
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453

Doximity (Doximity) Headlines

From GuruFocus